Clinical Trial Update: Lepticore in Metabolic Syndrome and Weight Loss [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating Lepticore for obesity, hyperlipidemia, hyperglycemia, and metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Hyperlipidemia
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Lepticore

Snippet

Sponsor: University of Yaounde 1 | Conditions: Obesity, Hyperlipidemia | Phase 1, Phase 2 | Status: COMPLETED